Peptron, Inc.
1 more in force is now held by another company
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
2
Ending by 2030
Jun 2028
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 3 fees due Feb 8 to 28, 2027 · next Feb 8
- 2 fees due Apr 3 to 13, 2027 · next Apr 3
Recent changes
- 1 of the patents on this record was granted since Aug 16, 2026
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,687,043 | Heat block assembly and organic compound synthesizing apparatus using the heat block assembly In force · From the USPTO record | In force | From the USPTO record | |
| US 9,155,702 | Composition and microsphere for controlled-release of exendin, and method preparing the same In force · From the USPTO record | In force | From the USPTO record | |
| US 8,829,044 | Stabilized vitamin C derivatives having a peptide molecule, preparation method thereof, and composition containing the same In force · From the USPTO record | In force | From the USPTO record | |
| US 9,757,757 | Ultrasonic atomizer for aseptic process In force · From the USPTO record | In force | From the USPTO record | |
| US 9,776,201 | Ultrasonic atomizer for aseptic process In force · From the USPTO record | In force | From the USPTO record | |
| US 11,273,130 | Methods of delivering a neuroprotective polypeptide to the central nervous system In force · From the USPTO record | In force | From the USPTO record | |
| US 11,771,657 | Methods of Delivering a Neuroprotective Polypeptide to the Central Nervous System In force · Low confidence | In force | Low confidence | |
| US 11,739,158 | Antibody binding specifically to MUC1 and use thereof In force · From the USPTO record | In force | From the USPTO record | |
| US 11,739,159 | Antibody binding specifically to MUC1 and use thereof In force · From the USPTO record | In force | From the USPTO record | |
| US 11,472,887 | Antibody binding specifically to MUC1 and use thereof In force · From the USPTO record | In force | From the USPTO record |
Also on record, not counted in the 13: 1 patent in force now held by others · 1 lapsed for an unpaid fee · 3 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
1 pending · 3 no status recorded